Skip to content
Governance Register

← US public companies

Zosano Pharma Corp

SEC CIK 1587221 · ZSAN · last insider filing 2022-06-07

Directors (from insider filings)

NameCapacity as filedFilings
Lo Steven Director · Chief Executive Officer filed 2019 - 2022
Yang Elaine Director filed 2021 - 2021
Greathouse Kenneth Director filed 2017 - 2021
Elms Steve Director filed 2018 - 2021
Xanthopoulos Kleanthis G Director filed 2015 - 2021
Grais Linda S Director filed 2019 - 2021
Hagan Joseph P Director filed 2015 - 2021
Mcgee Kathy M. Director filed 2021 - 2021
Walker John Peter Director · President and CEO filed 2016 - 2020
Wilson Troy Edward Director filed 2015 - 2019
Alataris Konstantinos Director · President, CEO filed 2015 - 2017
Barrett M James Director filed 2015 - 2017
Daddona Peter E. Director · Chief Scientific Officer filed 2015 - 2015
Lamba Vikram Director · President, CEO filed 2015 - 2015
Steel Bruce D. Director filed 2015 - 2015

Officers (from insider filings)

NameTitle as filedFilings
Matthews Christine See Remarks filed 2020 - 2022
Kellerman Donald J VP, Clinical Dev & Med Affairs filed 2016 - 2022
Lewis Hayley VP, Reg Affairs & Quality filed 2016 - 2021
Kitchener Gregory David Chief Financial Officer filed 2018 - 2019
Erbez Georgia Interim CFO filed 2016 - 2017
Tso Winnie Wing-Kei Chief Financial Officer filed 2015 - 2017
Scharin Eric VP, Engineering & Operations filed 2016 - 2016
Peri Laxmi Sr. Vice President, Operations filed 2015 - 2015
Strange Alexander Ramsay VP, Strategy & Corp. Develop. filed 2015 - 2015
Oza Nandan Chief Operating Officer filed 2015 - 2015

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.